Rituximab

A4DAB226 | Cancer | Approved
MS4A1/CD20
G1 / IgG1
Biogen Biogen Idec Cedars-Sinai Medical Center Chugai Pharmaceutical Genentech Hackensack University Medical Center Hoosier Cancer Research Network Janssen Research & Development M. D. Anderson Cancer Center Mayo Clinic Nagoya University Oregon Health & Science University Roche SCRI Development Innovations Takeda Oncology University of Gottingen University of Texas M. D. Anderson Cancer Center University of Tours Zenyaku Kogyo
Approved
Whole mAb
IDEC-102 IDEC102 IDEC 102 IDEC-C2B8 IDEC C2B8 RG 105 RG-105 RG105 Ristova Rituxan RO-452294 RO 452294 RO452294
6.5
Avg A4D Score
-0.6395
Score Range
-0.71 to -0.56
Structures
11
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB226_8vgn_H_L 8vgn 100% -0.5955 6.0 9.0 -0.2132 -0.6416
A4DAB226_2osl_A_B 2osl 100% -0.6719 6.0 9.0 -0.312 -0.7156
A4DAB226_8vgo_A_B 8vgo 98% -0.5644 6.0 9.0 -0.2059 -0.6074
A4DAB226_6vja_I_M 6vja 100% -0.7052 6.0 9.0 -0.2148 -0.7643
A4DAB226_8vgn_A_B 8vgn 100% -0.6033 6.0 9.0 -0.2087 -0.6508
A4DAB226_6y90_C_D 6y90 100% -0.6918 6.5 9.0 -0.2486 -0.7452
A4DAB226_4kaq_H_L 4kaq 100% -0.6261 6.5 9.0 -0.229 -0.6751
A4DAB226_6y90_H_L 6y90 100% -0.6861 6.0 9.0 -0.2485 -0.7388
A4DAB226_2osl_H_L 2osl 100% -0.6466 6.0 9.0 -0.3035 -0.6879
A4DAB226_8vgo_H_L 8vgo 98% -0.5706 6.0 9.0 -0.2087 -0.6141
A4DAB226_6vja_H_L 6vja 100% -0.6734 6.0 9.0 -0.2058 -0.7297